PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,285 | -69.1% | 236 | -44.1% | 0.00% | – |
| Q2 2023 | $17,104 | -36.7% | 422 | -24.2% | 0.00% | – |
| Q1 2023 | $27,015 | +93.0% | 557 | +54.7% | 0.00% | – |
| Q4 2022 | $14,000 | -39.1% | 360 | -21.6% | 0.00% | – |
| Q3 2022 | $23,000 | 0.0% | 459 | -21.7% | 0.00% | – |
| Q2 2022 | $23,000 | -25.8% | 586 | -29.5% | 0.00% | – |
| Q1 2022 | $31,000 | +6.9% | 831 | +11.8% | 0.00% | – |
| Q4 2021 | $29,000 | +31.8% | 743 | +24.5% | 0.00% | – |
| Q3 2021 | $22,000 | 0.0% | 597 | +13.5% | 0.00% | – |
| Q2 2021 | $22,000 | -31.2% | 526 | -20.2% | 0.00% | – |
| Q1 2021 | $32,000 | -22.0% | 659 | -2.2% | 0.00% | – |
| Q4 2020 | $41,000 | -25.5% | 674 | -43.3% | 0.00% | – |
| Q3 2020 | $55,000 | -11.3% | 1,188 | -3.4% | 0.00% | – |
| Q2 2020 | $62,000 | +21.6% | 1,230 | +7.8% | 0.00% | – |
| Q1 2020 | $51,000 | – | 1,141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |